» Articles » PMID: 34488935

Drug Evaluation Based on Phosphomimetic PDHA1 Reveals the Complexity of Activity-related Cell Death in A549 Non-small Cell Lung Cancer Cells

Overview
Journal BMB Rep
Date 2021 Sep 7
PMID 34488935
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer cells predominantly generate energy via glycolysis, even in the presence of oxygen, to support abnormal cell proliferation. Suppression of PDHA1 by PDK1 prevents the conversion of cytoplasmic pyruvate into Acetyl-CoA. Several PDK inhibitors have been identified, but their clinical applications have not been successful for unclear reasons. In this study, endogenous PDHA1 in A549 cells was silenced by the CRISPR/Cas9 system, and PDHA1WT and PDHA13SD were transduced. Since PDHA13SD cannot be phosphorylated by PDKs, it was used to evaluate the specific activity of PDK inhibitors. This study highlights that PDHA1WT and PDHA13SD A549 cells can be used as a cell-based PDK inhibitor-distinction system to examine the relationship between PDH activity and cell death by established PDK inhibitors. Leelamine, huzhangoside A and otobaphenol induced PDH activity-dependent apoptosis, whereas AZD7545, VER-246608 and DCA effectively enhanced PDHA1 activity but little toxic to cancer cells. Furthermore, the activity of phosphomimetic PDHA1 revealed the complexity of its regulation, which requires further in-depth investigation. [BMB Reports 2021; 54(11): 563-568].

Citing Articles

Targeting pyruvate dehydrogenase kinase 1 overcomes EGFR C797S mutation-driven osimertinib resistance in non-small cell lung cancer.

Park W, Wei S, Xie C, Han J, Kim B, Kim B Exp Mol Med. 2024; 56(5):1137-1149.

PMID: 38689087 PMC: 11148081. DOI: 10.1038/s12276-024-01221-2.


Natural Product-Based Glycolysis Inhibitors as a Therapeutic Strategy for Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

Park W, Han J, Wei S, Yang E, Cheon S, Bae S Int J Mol Sci. 2024; 25(2).

PMID: 38255882 PMC: 10815680. DOI: 10.3390/ijms25020807.


PDHA1 Alleviates Myocardial Ischemia-Reperfusion Injury by Improving Myocardial Insulin Resistance During Cardiopulmonary Bypass Surgery in Rats.

Chen K, Liu Z, Yi J, Hui Y, Song Y, Lu J Cardiovasc Drugs Ther. 2023; 39(1):17-31.

PMID: 37610688 DOI: 10.1007/s10557-023-07501-9.


Andrographolide suppresses aerobic glycolysis and induces apoptotic cell death by inhibiting pyruvate dehydrogenase kinase 1 expression.

Yang E, Do Y, Cheon S, Kim B, Ling J, Cho M Oncol Rep. 2023; 49(4).

PMID: 36825595 PMC: 9996679. DOI: 10.3892/or.2023.8509.


A novel defined cuproptosis-related gene signature for predicting the prognosis of lung adenocarcinoma.

Zhang H, Shi Y, Yi Q, Wang C, Xia Q, Zhang Y Front Genet. 2022; 13:975185.

PMID: 36046242 PMC: 9421257. DOI: 10.3389/fgene.2022.975185.


References
1.
Kato M, Li J, Chuang J, Chuang D . Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol. Structure. 2007; 15(8):992-1004. PMC: 2871385. DOI: 10.1016/j.str.2007.07.001. View

2.
Korotchkina L, Patel M . Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase. J Biol Chem. 2001; 276(40):37223-9. DOI: 10.1074/jbc.M103069200. View

3.
Golias T, Papandreou I, Sun R, Kumar B, Brown N, Swanson B . Hypoxic repression of pyruvate dehydrogenase activity is necessary for metabolic reprogramming and growth of model tumours. Sci Rep. 2016; 6:31146. PMC: 4976358. DOI: 10.1038/srep31146. View

4.
Moore J, Staniszewska A, Shaw T, DAlessandro J, Davis B, Surgenor A . VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells. Oncotarget. 2014; 5(24):12862-76. PMC: 4350332. DOI: 10.18632/oncotarget.2656. View

5.
Jeoung N, Harris R . Role of pyruvate dehydrogenase kinase 4 in regulation of blood glucose levels. Korean Diabetes J. 2010; 34(5):274-83. PMC: 2972486. DOI: 10.4093/kdj.2010.34.5.274. View